Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
261.32
252.84
209.04
369.12
255.76
227.49
195.16
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
261.32
252.84
209.04
369.12
255.76
227.49
195.16
Raw Material Cost
26.06
25.90
24.02
28.67
22.99
23.21
22.35
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.17
0.23
0.20
0.19
0.19
0.22
0.16
Selling and Distribution Expenses
109.37
113.15
116.29
130.99
102.01
104.15
101.28
Other Expenses
1.71
1.90
2.56
2.11
2.37
2.41
2.55
Total Expenditure (Excl Depreciation)
152.71
158.25
166.14
180.94
148.87
151.68
149.33
Operating Profit (PBDIT) excl Other Income
108.6
94.60000000000001
42.9
188.2
106.89999999999999
75.8
45.8
Other Income
4.88
36.27
5.50
8.12
10.86
8.18
13.38
Operating Profit (PBDIT)
125.21
146.02
52.38
210.10
128.57
97.51
67.81
Interest
0.17
0.23
0.20
0.19
0.19
0.22
0.16
Exceptional Items
1.57
1.75
1.80
0.30
0.93
0.40
3.19
Gross Profit (PBDT)
235.26
226.94
185.02
340.46
232.77
204.28
172.80
Depreciation
15.52
15.52
15.21
15.21
13.52
13.52
13.67
Profit Before Tax
111.08
132.01
38.77
195.00
115.79
84.16
57.17
Tax
16.59
15.27
5.57
29.94
16.69
12.41
9.70
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
94.22
119.23
36.07
167.86
102.67
74.34
45.57
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
94.22
119.23
36.07
167.86
102.67
74.34
45.57
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-2.16
-2.72
-3.22
-3.05
-3.79
-2.79
-3.73
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
92.06
116.51
32.85
164.81
98.88
71.55
41.84
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,754.36
2,738.68
2,619.45
2,635.74
2,467.88
2,428.05
2,353.71
Earnings per share (EPS)
0.18
0.23
0.07
0.32
0.2
0.14
0.09
Diluted Earnings per share
0.18
0.23
0.07
0.32
0.2
0.14
0.09
Operating Profit Margin (Excl OI)
40.11%
37.27%
15.15%
50.6%
40.74%
33.32%
20.88%
Gross Profit Margin
48.45%
58.35%
25.82%
56.95%
50.56%
42.94%
36.3%
PAT Margin
36.05%
47.16%
17.26%
45.47%
40.14%
32.68%
23.35%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 2.15% vs 20.09% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is -6.88% vs 43.96% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 2.21% vs 40.96% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 0.00% vs -33.33% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Compare Quarterly Results Of Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
261.32
0
261.32
Other Operating Income
0.00
0.00
0.00
Total Operating income
261.32
0
261.32
Raw Material Cost
26.06
0
26.06
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.17
0
0.17
Selling and Distribution Expenses
109.37
0
109.37
Other Expenses
1.71
0.00
1.71
Total Expenditure (Excl Depreciation)
152.71
0
152.71
Operating Profit (PBDIT) excl Other Income
108.62
0.00
108.62
Other Income
4.88
0
4.88
Operating Profit (PBDIT)
125.21
0
125.21
Interest
0.17
0
0.17
Exceptional Items
1.57
0
1.57
Gross Profit (PBDT)
235.26
0
235.26
Depreciation
15.52
0
15.52
Profit Before Tax
111.08
0
111.08
Tax
16.59
0
16.59
Provisions and contingencies
0
0
0.00
Profit After Tax
94.22
0
94.22
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
94.22
0
94.22
Share in Profit of Associates
0
0
0.00
Minority Interest
-2.16
0
-2.16
Other related items
0.00
0.00
0.00
Consolidated Net Profit
92.06
0
92.06
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,754.36
0
2,754.36
Earnings per share (EPS)
0.18
0
0.18
Diluted Earnings per share
0.18
0
0.18
Operating Profit Margin (Excl OI)
40.11%
0%
0.00
40.11%
Gross Profit Margin
48.45%
0%
0.00
48.45%
PAT Margin
36.05%
0%
0.00
36.05%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 26.13 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 3.36% vs 20.96% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 2.15% vs 20.09% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 9.21 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -20.94% vs 254.10% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -6.88% vs 43.96% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 12.03 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 9.56% vs 134.12% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 2.21% vs 40.96% in Jun 2025
Quarterly - Interest
Interest 0.02 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 0.00% vs 0.00% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 0.00% vs -33.33% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 40.11%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
